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This thesis is submitted as a series of papers relying on the three peer-reviewed 
studies included in the appendix. The thesis covers the background, results and 
critically reviews the methodology of these studies. Furthermore, the thesis 
discusses the clinical interpretation and limitations of the studies along with 
providing perspectives for future research. 
Paper 1: Qvist AH, Væsel MT, Jensen CM, Jensen SL. Plate fixation compared 
with nonoperative treatment of displaced midshaft clavicular fractures: a 
randomized clinical trial. Bone Joint J. 2018 Oct;100-B(10):1385-1391. doi: 
10.1302/0301-620X.100B10.BJJ-2017-1137.R3. PMID: 30295536. 
Paper 2: Qvist AH, Vaesel MT, Moss C, Jakobsen T, Jensen SL. No need to use 
both Disabilities of the Arm, Shoulder and Hand and Constant-Murley score in 
studies of midshaft clavicular fractures. Acta Orthop. 2020 Sep 15:1-5. doi: 
10.1080/17453674.2020.1820274. Epub ahead of print. PMID: 32928045. 
Paper 3: Qvist AH, Væsel MT, Jensen CM, Jakobsen T, Jensen SL. Minimal Pain 
Decrease Between 2 and 4 Weeks after Nonoperative Management of a 
Displaced Midshaft Clavicle Fracture Is Associated with a High Risk of 
Symptomatic Nonunion. Clin Orthop Relat Res. 2020 Jul 14. doi: 




The overall aim of this thesis was to improve functional results after treatment of 
midshaft clavicular fractures and to reduce the rate of secondary surgery.  
Study I was a randomized clinical trial comparing operative and non-operative 
treatment of adult patients with displaced midshaft clavicular fractures. 150 patients 
were divided into two equal groups and followed for one year. We measured the 
functional outcome as well as recorded the incidence of complications and 
nonunion. The functional outcome was measured with a patient reported score 
(Disabilities of the Arm, Shoulder and Hand, DASH) as well as a part patient 
reported and part examiner reported score (Constant Score, CS). We found that 
operative treatment reduces the risk of nonunion, but there is no benefit the 
functional outcome scores compared to nonoperative treatment. Furthermore, there 
is a risk of complications associated with the operative treatment.  
Study II was an analysis of the DASH and CS scores from Study I. The 
measurement properties of both measuring instruments were analysed and 
compared. We found that the instruments had similar properties and future studies 
could rely on the use of the DASH questionnaire alone.  
Study III was an analysis of the non-operatively treated patients from Study I. We 
investigated risk factors for the development of nonunion. We found that minimal 
improvement in pain scores in the period week two to week four after fracture was 
associated with a high risk of nonunion.  
The findings in this PhD dissertation contribute to the understanding of the treatment 
of mid-shaft clavicular fractures in adults. Study I contributes to a growing body of 
evidence suggesting that the only benefit of operative treatment is the reduced risk 
of nonunion. Study II provides an opportunity to ease the administrative and 
financial burden in future studies, as it is sufficient to use only DASH as a 
measuring instrument for functional outcome. Study III identifying slowly 
decreasing pain as a risk factor for nonunion. This finding must be validated in a 
new study before clinical use, but has the potential to change the current treatment 
of clavicular fractures to a more individual approach, where only patients at high 








Det primære formål med denne afhandling var at forbedre de funktionelle resultater 
efter behandling af midtskafts brud på kravebenet, samt reducere raten af sekundær 
kirurgi. 
Studie I var et randomiseret klinisk studie hvor man sammenlignede operativ og 
ikke-operativ behandling af voksne patienter med forskudte midtskafts 
kravebensbrud. 150 patienter blev fordelt i to lige store grupper ved lodtrækning og 
blev fulgt i et år. Vi målte det funktionelle resultat samt registrerede forekomsten af 
komplikationer og pseudoartrose.  
Det funktionelle resultat blev målt med en patient raporteret score (Disabilities of 
the Arm, Shoulder and Hand, DASH) samt en score bestående af både en patient 
raporteret del samt en del målt af en undersøger (Constant Score, CS). 
Vi fandt, at operativ behandling nedsætter risikoen for pseudoartrose, men der ses 
ingen gevinst i det funktionelle resultat. Ydermere er der risiko for komplikationer i 
forbindelse med den operative behandling. 
Studie II var en analyse af DASH og CS skemaerne fra studie 1. De målemæssige 
egenskaber ved begge måleinstrumenter blev analyseret og sammenlignet. Vi fandt, 
at instrumenterne havde de samme egenskaber, og at man i fremtiden kan nøjes med 
kun at bruge den patient rapporterede score (DASH). 
Studie III var en analyse af de ikke-operativt behandlede patienter fra studie I. Vi 
undersøgte risikofaktorer for udviklingen af pseudoartrose. Vi fandt at langsomt 
aftagende smerter i perioden uge to til uge fire efter kravebensbrud var associeret 
med en stor risiko for pseudoartrose. 
Fundene i denne Ph.D. afhandling bidrager til forståelsen af behandlingen af 
midtskafts kravebensbrud hos voksne. Studie I bidrager til en voksende mængde af 
evidens, der peger mod, at den eneste gevinst ved operativ behandling er den 
nedsatte risiko for pseudoartrose. Studie II giver mulighed for at lette den 
administrative og økonomiske byrde i fremtidige studier, da man kan nøjes med kun 
at anvende DASH som måleinstrument af funktionelt resultat. Studie III 
identificerede langsomt aftagende smerter som risikofaktor for pseudoartrose. 
Fundet skal valideres i et nyt studie før klinisk brug, men har potentiale til at ændre 
den nuværende behandling af kravebensbrud til et mere individuelt fokus, hvor kun 
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Displaced and comminuted midshaft clavicular fractures are 
common1–5.  The treatment of midshaft clavicular fractures has 
traditionally been non-operative supported by early papers reporting a 
low incidence of non-union and high patient satisfaction following 
non-operative treatment4,6. These early results were based on studies 
of both undisplaced and displaced fractures in adults as well as 
children. In contrast to the studies fra 1960s, in the late 1980s, it 
became increasingly clear that adult patients with displaced midshaft 
fractures had a high risk of non-union combined with a high risk of 
unsatisfactory functional outcome after non-operative treatment7–9. 
The first randomized clinical trial comparing operative and 
nonoperative treatment was published in 200710 and showed that 
patients treated operatively had a reduced risk of non-union along 
with a slight improvement in functional outcome scores compared to 
non-operative treatment.  To further investigate operative and 
nonoperative treatment of midshaft clavicular fractures a Danish 
randomized clinical trial was initiated in 2010 at Aalborg University 
Hospital, Viborg Regional Hospital and Randers Regional Hospital. 




























Figure 1. A graphical representation of studies 1-3.  
Red box: Study I. Comparison of Outcome scores, complication rates, 
non-union rates.  
Green box: Study II. Measurement properties of DASH and CS 
compared at each follow-up point.  
Blue box: Study III. Risk factors for development of non-union 
investigated and analysed. 







3.1 Modern treatment of midshaft clavicular fractures: A 
summary. 
 
In the 1960s Charles Neer and Carter Rowe independently published 
two large cohorts of clavicular fractures. These studies are widely 
regarded as the early foundation for the modern treatment of midshaft 
clavicular fractures. Following non-operative treatment Neer and 
Rowe reported low non-union rates of 0.13 and 0.8 per cent, 
respectively, following non-operative treatment and higher non-union 
rates of 4.4 and 3.7 per cent, respectively, following operative 
treatment4,6. 
The perception of operative treatment as a factor in the development 
of non-union discredited osteosynthesis and the standard treatment of 
midshaft clavicular fractures continued to be non-operative in the 
following decades. 
In the late 1980s, there was increased focus on patients with displaced 
fractures, and single cohort studies suggested that this subgroup of 
patients might have unsatisfactory outcomes7–9 after non-operative 
treatment and that operative treatment may yield good results12. 
A metaanalysis performed in 20052 on available data of 618 patients 
with displaced midshaft clavicular fractures showed a significantly 
lower non-union rate following operative treatment compared to 
primary non-operative treatment (2.2 % vs. 15.1 %). 
In 2006 McKee et al.13 published a cohort of patients with non-
operatively treated displaced fractures and reported that functional 
outcome as measured by Constant Score14 (CS) and Disabilities of the 
Arm, Shoulder and Hand15 (DASH) score was worse than the 
published normative value for the general population, indicating room 
for improvement in the treatment of displaced fractures.  
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The first randomized trial comparing operative and non-operative 
treatment of midshaft clavicular fractures was published in 2007 by 
the Canadian Orthopaedic Trauma Society (COTS)10. In this trial, 132 
patients with displaced midshaft clavicular fractures were randomized 
to operative treatment with plate and screws or non-operative 
treatment with a sling. The rate of non-union was 3.2% following 
operative treatment and 14.2% following non-operative treatment and 
at one year follow-up patients in the operative treatment group had a 
DASH score approximately 10 points better that the non-operative 
treatment group. 
In the following years more randomized trials16–21 were published and 
in 2017 a metanalysis22 on all available randomized studies showed 
that operative treatment reduced the rate of non-union (1.9 % vs. 16.5 
%) and reported a mean DASH score difference of 5.07 points (95% 
CI 0.06 to 10.08) favouring operative treatment. This difference of 
5.07 points is lower than the 10 point clinical relevant difference23, 
and it seems that the only long term benefit of operative treatment is 
the reduction of non-union risk. To reduce the non-union risk from 
16.5 % to 1.9 % on a group level would mean that 6.8 patients (The 
number-needed-to-treat24 (NNT)) needs operative treatment to avoid 
one non-union in that group.  
The need for a secondary operation was similar in the two groups 
(17.6 % operative vs. 16.6 % non-operative) with plate removal as the 
primary secondary operation in the operative treatment group and 
non-union treatment as the primary reason for secondary surgery in 
the non-operative treatment group.  
The combination of no long term functional outcome improvement 
and high rate of secondary surgery following operative treatment 
along with an NNT of 6.8 to avoid one non-union lead the conclusion 
that the authors “do not advocate routine plate fixation for all 
patients, but rather an individualized treatment based on shared 
decision-making, guided by the presence of risk factors for nonunion 




3.2 Complications following treatment of midshaft clavicular 
fractures 
 
The complications following treatment of midshaft clavicular depends 
on which primary treatment has been used. Non-union and malunion 
are the most common reported complications after non-operative 
treatment. After operative treatment the most common complications 
is hardware issues and infection. 
3.3 Complications associated with non-operative treatment 
 
Definition of non-union 
 
Symptomatic non-union has been shown to be both a painful and 
debilitating disease25–27. Non-union is generally defined as lack of 
radiological and/or clinical healing along with a specific time limit, 
but the defining features are ill-defined across the literature. In 1988 
the American Food and Drug Administration generelly defined a non-
union as "established when a minimum of 9 months has elapsed since 
injury and the fracture shows no visible progressive signs of healing 
for 3 months"28. 
In the context of clavicular fractures neither Neer6, Rowe4 or Hill8 
defined non-union. In 1998 Robinson29 defined a time limit of a 
minimum of 24 weeks from fracture to non-union diagnosis and in 
2004 the same author30 defined union as ”the absence of mobility or 
pain on stressing the site of the fracture and evidence of bridging 
callus on radiographs” and nonunion as fractures that did not meet the 
criteria of union. In a metaanalysis from 2005 Zlowodzki defined non-
union as failure of osseous union2.  
In 2014 a systematic review with the aim of identifying predictors 
associated with non-union and malunion Jørgensen et al31 found that 
the time limit defining non-union varied from 16 weeks to 52 weeks, 
and some reviewed studies did not define non-union at all. In a 
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metaanalysis of randomized trials Woltz found similar variations in 
defining time limit along with the use of either computer tomography 
(2 studies) or radiographs (4 studies) to establish the absence of 
cortical bridging22.  
 
 
Non-union rates  
 
Following the series reported by Neer6 and Rowe4, the rate of non-
union after non-operative treatment of clavicular fractures was 
believed to be lower than one per cent. In these studies both 
adolescent and adult patients were included, displaced and 
undisplaced fractures were pooled together and operative treatment 
was performed on some of the displaced fractures; all factors which 
may have lead to underestimation of the true rate of non-union in 
adults. In 1997 Hill showed a 15 per cent rate of non-union in a cohort 
of non-operatively treated displaced midshaft clavicular fractures, 
which suggested that the risk of non-union in this subpopulation could 
be substantially higher than previously believed8. Similar to the 
findings of Hill8, Robinson showed in 1998 that 9.4 per cent of cases 
with complex comminuted displaced midshaft fractures went on to 
develop a non-union29. Based on non-randomized studies a 
metaanalysis2 from 2005 showed a 15.1 per cent non-union rate and in 
2017 a metaanalysis22 based on randomized studies showed a 16.5 per 
cent non-union rate, and given these rates, non-union appears to be 
much more common than previously believed. 
Due to the high rate of non-union and the associated disability of 
symptomatic non-union; non-union is the single most common and 







The increased awareness of potential malunion following 
nonoperative treatment of midtshaft calvicular fractures has been 
attributed to Eskola7 and Hill8, but earlier reports of malunion 
following midshaft clavicular fractures can be traced back to a case 
series from 1980 describing subclavian-axillary vein compression of 
musculoskeletal origin32. In the mid 1990s malunion seems to be 
purely defined as a fracture healed with deformity, as Simpson25 
describes that “most patients with malunion function well”. In 1998 
Nordqvist9 defined malunion based on radiographic findings, stating 
that malunion was present, if the fracture had united “with more than 
one bone width of fragment displacement or angulation of >30 
degrees”. This radiographic definition is not adopted across the 
literature, and in 2003 McKee33 states that  “Radiographic evidence of 
malunion is universal following displaced fractures of the clavicle”, 
meaning that all displaced fractures heals with a deformity.  
Brachial plexus compression and thoracic outlet syndrom34 along with 
more broad symptoms such as dysfunction and pain13,33 has been 
attributed to malunion. 
In the recent randomized studies malunion was defined as the 
combination of radiographic union with deformity and the presence of 
broad clinical undefined symptoms such a weakness, fatigue or 
neurovascular deficiets10,16.  One study diagnosed malunion if surgery 
for symptoms thought to be related to deformity had been perfomed20. 
In other studies malunion has been reported without a definition18, 
mentioned but not reported21 or not defined or reported at all17,19. No 
studies gave a defining time frame for the diagnosis of malunion.  
For midshaft clavicular fratures various degrees of shortening has 
been associated with malunion, however a large systematic review did 
not find no significant association between fracture shortening and 
shoulder outcome scores35.  
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3.4 Complications associated with operative treatment 
 
The most common complications after operative treatment are implant 
related, where the revision rates vary from 9% to 64% following 
operative treatment36. In a metaanalysis of randomized controlled 
trials Woltz reports a secondary surgery rate of 17.6%22, whereof most 
surgeries are implant removals, mostly due to hardware irritation. 
Hardware failure and secondary dislocation are not common. 
In general, infection rates are lower than 10%, and most infections are 
superficial22,36. Brachial plexus symptoms and regional pain 
syndromes can be common with a reported rate up to at 38%, but are 
for the most part transient22,36. Persistent numbness of the skin is 
common with a reported range of just below 20%18,20. In randomized 
studies, the rate of non-union following plate fixation is lower than 
2%21,22. 
 
3.5 Functional outcome scores used in clavicular fracture 
research. 
 
With the purpose of evaluating outcome after nonoperative treatment 
of midshaft clavicular fractures with patient-oriented health measures 
and objective muscle-strength testing McKee used both the CS and 
DASH score in 200613. The use of both CS and DASH in the 
evaluating of midshaft clavicular fractures was widely adopted and 
used in most of the subsequent randomized controlled trials21,22.  
In 1987 CS was developed as a clinical method of shoulder function 
assessment14. DASH was developed in 1996 with a of purpose of 
assessing symptoms and functional status in populations with upper 
extremity musculoskeletal conditions15.  
The CS score ranges from 0 to 100 points with 100 point representing 
a healthy functioning shoulder. The examiner reported part (range of 
motion and power) of CS accounts for a total of 35 points, while the 
patient reported part (pain and activities of daily life) accounts for a 
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total of 65 point, with one question regarding pain accounting for 15 
points.  
The DASH score ranges from 0-100 points based on a 30 item self-
reported questionnaire. A DASH score of 0 points represents normal 
shoulder function. 
The use of CS introduces observer bias and the measurement of power 
poses a problem, as some healthy individuals lack the ability to score 
the maximum 25 points on the power subscale37–39.  
Good convergent validity may exist between DASH and CS, as good 
correlation between the scores has been shown in different shoulder 
pathologies including clavicular fractures40–43. 
 
3.6 The Development of Patient Related Outcome 
Measurements 
 
Three stages exist for the development of patient related outcome 
measurements (PROM)44,45. The first stage is generation of 
questionnaire items thru a review of the background literature. All 
relevant items are included. The second stage is item reduction. 
Experts review the proposed items, and the items are tested on 
patients in a small-scale study. The item list is then reduced. After 
initial item reduction the item list is tested in large scale on patients 
and further reduced based on statistical methods and judgment by 
experts and patients. Finally, at the third stage, the reliability, validity, 
responsiveness and interpretability of the PROM is assessed46,47.  
Overall the reliability of a PROM relies on the PROMs ability to 
measure the same scores in different settings of repeated 
measurements. The repeated measurements could be: over time (test-
rest of patient with unchanged health status), by the same person on 
different occasions (intrarater), or using different sets of items from 
the same PROM (internal consistency). The validity of a PROM is an 
evaluation of the degree to which the instrument measures the 
constructs it is developed to measure; does the PROM relate to a gold 
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standard and does different scores relate to other similar measures as 
expected based of previously hypotheses concerning this relationship? 
Responsiveness is a measure for the PROMs ability to detect a change 
in health status of time. Interpretability is the ability to assign 
qualitative meaning to the PROM scores and changes in scores.  
In the development of the DASH questionnaire the first stage of item 
generation led to the identification of 821 items of interest15. A group 
of three experts reduced the list to 177 items, which was further 
reduced to 78 items, after further review and small scale pretesting on 
patients. The 78-item questionnaire was then tested in large scale on 
patients and reduced to the known 30-item DASH questionnaire48. A 
reliability, validity, responsiveness study was then performed, and the 
questionnaire was found to have sufficient validity and responsiveness 
in both proximal and distal disorders of the upper extremity49. 
3.7 Risk factors for the development of non-union 
 
In an attempt to identify patients at high risk of non-union following 
non-operative treatment various risk factors for the development of 
non-union has been described. 
In 1997 Hill8 reported  that fracture shortening ≥ 2 centimetres was 
associated with the development of non-union. In this retrospective 
study of 52 midshaft clavicular fractures no association between age, 
gender, occupation, smoking status, mechanism of injury, or the 
presence of associated injuries and non-union was found.  
In another retrospective study of 185 fractures with a average follow-
up of 17 years, Nordqvist9 found no evidence that the risk of non-
union could be based on the appearance of the fracture. In a case 
series of patients referred with persistent symptoms after non-
operative treatment of midshaft clavicular fractures Wick found that 
91%(n=30) of the fractures were shortened by at least 2 cm, and 
recommended that these fractures should be treated with 
osteosynthesis, if there were no callus formation after 6 weeks. 
Kirmani50 found no difference in secondary surgery (due to 
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symptomatic non-union) rates between a cohort with the radiological 
signs of a intermediate vertical fragment and a cohort with no sign of 
such fragment.  
Postacchini51 reported a case series of nonoperatively treated midshaft 
fractures with mean follow-up of 8.7 years and found that the 
presence of a third fragment did not predispose to failure of fracture 
healing. The study reported that patients with non-union had less 
radiographic displacement and more shortening compared to patients 
with union, but of this difference no statistical analysis or confidence 
intervals were reported. 
In a systematic review of these retrospective cohort and case series 
studies with the aim of identifing predictors associated with nonunion 
or symptomatic malunion Jørgensen31 found that displacement was 
most likely a predictor for non-union, while evidence for other factors 
(smoking, fracture comminution, age , gender and shortening) was 
limited. 
Most of the recent randomized controlled trials did not explore for 
potential association between baseline characteristics and non-
union16,19–21. The Canadian study10 found an association between total 
displacement (combined vertical displacement and shortening at the 
fracture site) and inferior DASH scores at one year in the 
nonoperative group. As non-unions in this study were untreated and 
included in the one-year end analysis, inferior DASH scores at that 
time point could be due to negatively influence from the non-union 
cases. Association between non-union and increasing displacement 
was found by Virtanen17. In a combined analysis of operatively and 
non-operatively treated patients Robinson18 showed that positive 
smoking status was associated with non-union.  
Three prediction models for estimating the risk of non-union have 
been developed: 
 
1: In a prospective cohort from 2004 based on 581 midshaft fractures 
with the aim of estimating the risk of non-union following non-
operative treatment Robinson30 found that risk of non-union increased 
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with the presence of displacement and comminution along with 
increasing age and female gender. Robinson used Cox Regression 
Modelling to calculate a diagnostic index, where the above-mentioned 
factors were given different weights, and the diagnostic index could 
be used to estimate the risk of non-union at six, twelve, and twenty-
four weeks.  
 
2: A more simple approach was taken by Murray52 in 2013, where the 
risk of non-union in 941 displaced fractures was examined. Murray 
found that the presence of comminution and positive smoking status 
increased the risk of non-union. Non-union risk increased with 
increasing fracture displacement. A Logistic Regression Model was 
developed to estimate the risk of non-union. This model showed more 
than 90 per cent risk of non-union in a patient with positive smoking 
status and a comminuted fracture with 4 centimetres of displacement.  
 
3: In a new study with a cohort of 200 patients it was found that at six 
weeks a QuickDASH score of ≥40 points, no callus on radiographs, 
and fracture movement on examination were significant predictors of 
nonunion53. 
 
Other studies have shown that pain and early poor clinical results may 
be possible predictors for non-union. Pain at rest at 4 weeks follow-up 
was found to be more present in patients with non-union compared to 
patients with union in a 2004 study examining 222 fractures54. In the 
same cohort Nowak55 also reported that displacement and 
comminution was associated with patient reported fracture sequelae 
after 9 to 10 years of follow-up. In a study based on data from a 
previous randomized trial30 Clement56 showed that both smoking and 
a DASH score of > 35 points at six weeks following fracture was 
associated with the development of non-union. 
Most recently a study57 showed that the sonographic absence of 
bridging callus at six weeks was associated with non-union. In this 
study positive smoking status was also found to be associated with 
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non-union while age, comminution and gender was not. The clinical 
usefulness of these models remains unclear, as none of the mentioned 
prediction models have been externally validated. The variables used 
in prediction modelling can be classified as “Patient Specific”, 
“Fracture Specific” or as proxy variables for healing (Fig 2).  
 
 
Fig 2.  A model for prediction of fracture healing. The variables listed 
are examples of possible predictors. 
 
Both the patient specific and fracture specific variable group has the 
potential to contain undiscovered or unstudied variables such as 
“Generic predisposition to slow healing” or “Degree of interposed 
tissue”. This problem of unknown predictor variables could be 
bypassed by using proxy variables for healing58. A proxy variable for 
healing is an indirect measurement of fracture healing, and contains 
all the effect of all possible known and unknown patient specific or 
fracture specific variables. This means that a good proxy variable 
could predict non-union risk without information about the baseline 






4. Aim and hypotheses 
 
 
The overall aim of this thesis was to improve functional results after 
treatment of displaced midshaft clavicular fractures and to reduce the 




Study I.  
 
Null hypothesis: Operative treatment with locking plate 
and screws yields no changes in functional outcome 
scores and no reduction in nonunion rates compared to 
non-operative treatment in displaced midshaft clavicular 
fractures. 
 
Alternative hypothesis: Operative treatment with 
locking plate and screw yields improved functional 
outcome scores and a reduction in nonunion rates 
compared to non-operative treatment in displaced 














Study II.  
 
Null hypothesis: There is no convergent validity 
between Disabilities of the Arm, Shoulder and Hand and 
Constant-Murley scores in patients with displaced 
midshaft clavicular fractures. 
 
Alternative hypothesis: Convergent validity exists 
between Disabilities of the Arm, Shoulder and Hand and 
Constant-Murley scores in patients with displaced 





Study III.  
 
Null hypothesis: Minimal Pain Decrease in the early 
weeks following fracture is not a risk factor for 
development of non-union following non-operative 
treatment of displaced midshaft clavicular fractures. 
 
Alternative hypothesis: Minimal Pain Decrease in the 
early weeks following fracture is a risk factor for 
development of non-union following non-operative 




5. Methodological considerations 
 
5.1 Ethical Considerations and permissions 
 
Data for all studies was obtained through a single randomized 
controlled trial. Overall design is presented I fig. 1. The study was 
approved by the Scientific Ethics Committee of the Region of 
Northern Jutland (N-20090054) and the Danish Data Protection 
Agency (j.nr. 2013-41-1457). All patients gave their informed content 
to participate. The project was registered with www.clinicaltrials.gov 
(ClinicalTrials.gov Identifier: NCT01078480). The study was 


























The study population was defined by inclusion and exclusion criteria 
as available in table 1 
 
Inclusion criteria 
 1. Age between 18 and 60 years  
 2. Displaced midclavicular fracture  
Exclusion criteria 
 1. Bilateral fractures 
 2. Impending perforation of the skin 
 3. Open fracture 
 4. Neurovascular injury 
 5. Another fracture in the same limb 
 6. Pathological fracture 
 7. A history of symptoms from the shoulder 
 8. Previous clavicular fracture 
 9. More than two weeks since the injury 
 10. Cognitive impairment 
 11. Inability to follow the protocol of treatment 
 12. Contraindications to general anaesthesia or surgery 
Table 1. Inclusion and Exclusion criteria for study 1. 
 
 
The age limit for inclusion primarily had the purpose of excluding 
children and adolescents in which the healing rates are different and 
plate osteosynthesis is not considered a first choice.  The age limit 
was set at 60 years to exclude older patients, where the risk of failure 
and complications could be high compared to a younger population. 
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Furthermore as we expected the mean age for the population to be 
lower than 40, the inclusion of a few older patients with a high risk of 
complications could skew the results in either group. Also, a 
population older than 60 could meet a wide range of the exclusion 
criteria, which would limit the generalizability of the study, if a large 
group of screened patient was excluded. 
The exclusion criteria excluded patients with traditional indications 
for surgery such as impending perforation of the skin, open fracture, 
neurovascular injury and to a lesser extent pathological fracture and 
another fracture in the same limb. Conditions such as bilateral 
fractures, a history of symptoms from the shoulder or previous 
clavicular fracture could potentially affect DASH and Constant 
scores, and were also excluded. 
 
Intention to treat principle 
 
 
In study I patients were followed based on initial randomization 
according to the intention-to-treat principle59,60. This means that 
patients with surgical treated non-union after nonoperative treatment 
were analysed together with the remaining nonoperative treatment 
group. Similary a patient in the operative treatment group who 
declined surgery was followed in the operative treatment group. 
Intention-to-treat analysis is used to minimize bias in randomized 
controlled trials and deals especially with issues of noncompliance 
and missing data60. Reflecting a true clinical setting the intention-to-
treat principle is used to compare treatment strategies where patients 
may not always adhere to a strict treatment protocol. With increasing 
deviations from the treatment protocol, an intention-to-treat analysis 
gives more information about difference between the treatment 
strategies than the absolute difference between treatments. The 
intention-to-treat principle ”is generally interpreted as including all 
patients, regardless of whether they actually satisfied the entry 
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criteria, the treatment actually received, and subsequent withdrawal 
or deviation from the protocol”61, which was not done in our study, as 
patients lost to follow-up were not included in end analysis. A true 
application of the intention to treat principle can only occur if 
complete outcome data are available for all randomized subjects60. No 
consensus exists about the treatment of incomplete data and numerous 
methods for imputation of missing data exist61. In study I, II and III 
patients lost to follow-up were excluded from end analysis and 
outcomes were not imputed, and the use of the intention-to-treat 
principle in this study is more an overall design feature with the intent 
of analysing non-unions in the nonoperative treatment group and 
comparing treatment strategies, than the application of a specific 
statistical analysis method. 
 
Midclavicular and Displacement definition 
 
In this study “midclavicular” was defined as the middle one third of 
the clavicula. In other randomized studies the definition of “midshaft” 
varies from the “intermediate three-fifths of the diaphysis”18,20,21 to 
the ”middle-third”17,19 to no definition at all10,16. In this study a 
displaced fracture was defined as a fracture with no cortical contact 
between the two main fragments on at least one of two radiographs. 
This definition was adopted from the COTS randomized trial10, as no 
clear definition of displacement existed in the literature. In later 
randomized trials the definition of displacement varies from “at least 1 





As standard two radiographs was taken with an anteroposterior 
direction and a 30° angle between the projections in the sagittal plane. 
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No control of radiologic technique was planned, and it is possible that 
projection technique varied between centres. None of the other 
randomized trails specify theirs radiographic technique. All 
radiographs were reviewed at study completion. 
Follow-up 
 
Clinical and radiographic follow-up occurred after six weeks and after 
three, six, and 12 months. The timeframe and intervals for follow-up 
and one-year follow-up was considered to be standard at the time. 
This timeframe and the intervals for follow-up are in general similar 




The Disabilities of the Arm, Shoulder and Hand questionnaire  
 
The primary outcome in study I was the score of Danish version of the 
disabilities of the arm, shoulder and hand (DASH) questionnaire15 at 
one-year follow-up. The DASH questionnaire was developed with a 
systematic approach and a defined purpose of assessing symptoms 
and functional status in populations with upper extremity 
musculoskeletal conditions15. The DASH score is a 30 item self-
reported questionnaire, with most questions covering activities of 
daily life and symptom severity.  Questions are answered by response 
of: ”No difficulty”, ”Mild difficulty”, ”Moderate difficulty”, ”Severe 
difficulty”, ”Unable” or a similar range. Points on a range from 1-5 
are assigned to each response. The DASH score is calculated as the 
average of assigned values for all completed responses, which 
produces a score from 1 to 5. This value is transformed to a score out 
from 0 to 100 by subtracting one and multiplying by 25. A DASH 
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score cannot be calculated if 4 items or more are missing. A DASH 
score of 0 points represents normal shoulder function and a score of 
100 represents severe disability. A 10 point difference between in 
mean DASH score is considered to be the minimal important 
change23. The Danish version of DASH questionnaire was validated in 
patients with fractured wrists in 201162. Overall the DASH 
questionnaire has been widely validated63, but is not validated 
specificly in patients with clavicular fractures. The DASH 
questionnaire should be considered as a score for general upper 
extremiy function and not shoulder specific. 
Constant score  
 
The Constant Score14(CS) is a shoulder specific score that ranges from 
0 to 100 points with 100 point representing normal shoulder function. 
CS combines performance-based measures with patient reported 
outcomes. The performance-based measure is an examiner reported 
evaluation of range of motion and strength for a total of 65 points. The 
patient reported outcomes (pain and activities of daily life) accounts 
for a total of 35 point, with one question regarding pain accounting for 
15 points. Due to confusion surrounding the measurement of strength, 
updated guidelines for the use of constant score was published in 
200864. The 2008 guidelines states that strength should be measured 
with a isometric dynamometer placed at wrist level with the shoulder 
at 90 degrees of abduction in the scapular plane. If the patient is 
unable to achieve 90 degrees of abduction, a strength score of zero is 
assigned. In the present studies strength was measured with a 
isometric dynamometer (Mecmesin Myometer, Mecmesin, West 
Sussex, UK) according to the 2008 guidelines. In a study of rotator 
cuff surgery the minimal clinical relevant difference for the CS has 
been shown to be 10.4 points65. The documentation of the 
development of CS is lacking, and no systematic approach seems to 
have been applied in the development of the score, where subjective 
and objective measurements are arbitrary combined with no reasoning 
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for the selection of items or weight of each item. Despite the 
shortcomings in development CS is widely accepted as a 
measurement for shoulder function63. In 2016 Ban et al. found high 
interrater reliability, high convergent validity and good internal 
consistency of the total CS for patients with clavicle fractures after 
aplciation of a new standardized measurement protocol. Overall no 
golden standard for the functional measurement of the shoulder exists, 
but after McKees study on deficits following nonoperative treatment 
of midshaft clavicula fractures13 both DASH and CS have been 





Patients reported current pain from the facture site on a visual 
analogue scale once a week in the first six weeks following fracture. 
 
 
Fig 3.  Picture of VAS scale in pain diary. The scale was 10 cm, with no pain at the 




Nonunion was defined as radiographic lack of callus formation, 
persistent fracture lines, and/or sclerotic edges of the bones at the 
fracture site at six months. The nonunion was regarded as 
symptomatic if these findings were combined with pain at the fracture 
site, tenderness and local crepitation. Nonunion was diagnosed and 






Complications such as infection, neurovascular damage or adhesive 
capsulitis were registered at each follow-up point. At six months 
patients with symptomatic hardware were offered plate removal, if the 
fracture was united. Complication registration was done at each centre 
without a specific definition for each possible complication. No 
complication reporting classifcation was used. 
 
5.3 Sample size calculation 
 
Risk of type I error (α) was 5% and the power (1-β) was set to 80%.  
A standard deviation (σ, SD) of 20 points for the DASH score was 
assumed and clinically relevant difference (d) in DASH score was 
1023. DASH score was chosen as the primary outcome based on the 
COTS randomized trial10.  SD was arbitrary set to 20, as earlier 
studies10,13 did not provide a SD for DASH scores. 
Sample size for each group66 was calculated as: 
na =((Za + Z1-b)2 x 2 × σ2)/d2 
na= ((1.96 + 0.84) 2 2 x 202))/102  
na=(7.84 x 2 x 400)/100 = 62.7 
63 patients were required in each group. Allowing for loss to follow-




The randomization table was computer-generated. Allocation was 
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concealed with sealed envelopes and stratified by the surgical centre 
using blocks of ten. Each block had an equal allocation of non-




Per design blinding of surgeon or patient was not possible. A 
specialist nurse blinded to treatment recorded the Constant score and 
the patients were encouraged not to tell which treatment they had 
received, and clothes covered both shoulders. 
 
5.6 Data collection 
 
Data was collected locally on paper forms. At the end of the study all 
data was entered into a central database. Validation was done by 
double data entry.  
 
5.7 Non-operative treatment 
 
Patients were treated with a sling (Collar’n’Cuff, Mölnlycke Health 
Care, Sweden) for a maximum of three weeks.  Use of arm and 
shoulder within the limits of pain was allowed. Patients were not 
offered physiotherapy. 
 
5.8 Operative treatment 
 
Operative treatment was completed within 14 days of the injury. 
General anaesthesia and a single dose of intravenous prophylactic 
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antibiotic were used. The fracture was exposed and reduced before 
stabilizing with precontured plate and locking screws. At least three 
bicortical screws were placed in each main fragment, and two of those 
were locking screws. Postoperatively patients were treated with a 
sling (Collar’n’Cuff, Mölnlycke Health Care, Sweden) for a 
maximum of three weeks.  Use of arm and shoulder within the limits 
of pain was allowed. Patients were not offered physiotherapy. 
 
 
5.9 Treatment of non-union and complications 
 
The treatment of symptomatic non-union consisted of surgery with 
debridement, reaming of the medullary canals, and fixation with a 
plate. Autologous bone graft was used if necessary. 
Other treatment failures were treated according to centre guidelines.  
 
 
5.10 Bias considerations 
  
Randomized trials are considered to be at the top of the evidence 
hierarchy, as randomization is an excellent tool to reduce bias. 
However some potential for bias arises from the randomized 
controlled trial design. According to the Cochrane handbook for 
systematic reviews the specific domains for risk of bias in randomized 
trials are: (1) bias arising from the randomization process, 
(2) bias due to deviations from intended interventions, (3) bias due to 
missing outcome data, 






(1) bias arising from the randomization process 
 
Bias can occur in the randomization process when patients are 
accepted or rejected to participate in a trial, or when the intervention 
is allocated. The bias occurs when the investigator interferes 
(consciously or unconsciously) with study inclusion or treatment 
allocation based on knowledge of the randomization. In this study we 
used blocks of ten patients with an equal treatment allocation. In the 
present studies there is a risk of bias as allocation concealment is 
reduced since there is a known number of each treatment allocation in 
a block. Depending on the sequence the envelopes are opened, one or 
more of the last allocations may be known.  
 
(2) bias due to deviations from intended interventions 
 
Possible bias due to deviations from intended interventions depends 
on the trial setup (‘intention-to-treat” or ‘per-protocol”). This study 
was designed to study the effect of assignment to the intervention at 
baseline (‘intention-to-treat”), and in that context the possible 
deviations are those that: 
 
(a) could arise because of the trial context: 
 
The lack of blinding of study participants could lead to a situation, 
where participants allocated to nonoperative treatment feels “unlucky” 
and drops out to seek surgical treatment elsewhere. Furthermore 
investigators, who are not blinded may give increased attention to a 
certain treatment group and thus introduce bias. A surgeon biased 
towards surgical treatment might give increased attention to this group 
as a whole, which would affect the results of the trial. The increased 
attention could come in the form of clinical visits more frequent than 
specified in the study protocol or simply more positive attention 
during planned clinical visits. Clinical visits beyond the specified 
follow-up time points were not registered in the trial.  Furthermore 
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secondary treatment and investigations after treatment allocation 
could be based on the knowledge of the treatment allocation. Blinding 
is difficult in surgical trials, and blinding of study participants or 
surgeons was not an option in the present study. 
A possible overestimation of non-union risk could arise due to 
delayed inclusion. Patients with decreasing pain might not be willing 
to participate in a study with a risk of surgical treatment when asked 
late (14 days) in the study inclusion period. If pain were associated 
with non-union this would lead to an overestimation of non-union risk 




(b) would be inconsistent with the trial protocol: 
 
Inconsistency with trial protocol could range from simple deviations 
such as changes in follow-up or the use of a different type of sling to 
the more severe case such as the use of non-protocolized surgical 
techniques. As all radiographs were reviewed at study completion any 




(c) could influence the outcome: 
 
This study was designed to study the effect of assignment to the 
intervention at baseline. If a large number of patients did not receive 
the intended intervention, several possibilities for over- or 
underestimating treatment effects would arise. An example of this 
could be a scenario where patients in the non-operative group opt for 
surgical treatment due to pain issues in the early weeks following 
fracture. This could lead to an underestimation of non-union risk in 
the non-operative group, as surgical treatment reduces the risk of non-
union. In this effect a per-protocol analysis would also be of little 
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value, as the allocation to either treatment would no longer be 
randomized. 
 
(3) bias due to missing outcome data 
 
This type of bias could occur, when there are systematic differences 
between the two groups withdrawing from the study. It could be 
present in this study if patients in the non-operative group withdraws 
to seek surgery elsewhere, and if patients withdraws because their 
outcome is good and they no longer feel the need to be reviewed.  
 
 
(4) bias in measurement of the outcome 
 
This type of bias could occur when a systematic difference in the 
observation of treatment results is present. Study participant or 
investigators may affect outcome measurements based on the 
knowledge of the treatment allocation. In the present study we sought 
to reduce the risk of detection bias by encouraging the participants not 
to tell which treatment they had received, and by covering both 
shoulders with clothes as to blind the specialist nurse who recorded 
the Constant Score. As the participants were not blinding the DASH 
scores and the patient reported parts of the Constant Score could be 
potentially be influenced by bias.  
 
(5) bias in selection of the reported result. 
 
This type of bias occurs in situations where outcome measures (end-
points) or statistical analysis are specified post hoc based on available 
data; when only the most favourable result from a variety of different 
measurements is reported or when reporting the most favourable 
result of multiple possible adjustment in the statistical analysis. This 
type of bias is often seeked to be reduced by publishing study 
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protocols and statistical analysis plans prior to study completion. At 
the time of planning this study, the publishing of study protocols and 
statistical analysis plans was not considered as standard procedure. 
 
 
5.11 Special methodical considerations. 
 
The following describes special considerations for each study. A full 




Study I considerations 
 
By presenting the option of plate removal to patients with 
symptomatic hardware there is a risk of inducing plate removal. The 
same kind of risk is present in the treatment of non-unions, where 
patients are closely followed and offered treatment at six months if a 
symptomatic non-union is present. The option of plate removal and 
the close following of possible non-unions both introduces a risk of 
overestimating the rate of secondary surgery compared to normal 
clinical practice. In both cases normal clinical practice is that patients 
with sequelae from either operative or non-operative treatment is 
referred by their general practitioner to an orthopaedic specialist, 
which does not fit the trial setup in study I.  
 
Study II considerations 
 
Study II examines the convergent validity between DASH and 
Constant score based on the assumption that both scores tests for 
disability following midshaft clavicular fracture. As patients in the 
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cohort are otherwise healthy in regard to shoulder function, this 
assumption is believed to be valid. No golden standard to assess 
disability following midshaft clavicular fracture exists, and therefore 
only a comparison between DASH and Constant score is possible.  
In study II the Bland-Altman plot is used to study the agreement 
between the two scores. The width of the confidence intervals 
surrounding the estimates is determined in part by the sample size. 
Martin Bland68 recommends a sample size of 100. 
In correlation, power calculations are used when determining whether 
a correlation coefficient differs from zero. If the expected correlation 
coefficient is low, a large sample size is required than if a higher 
correlation coefficient is expected69. We expected moderate to high (r 
>0.5) correlation between the two scores, which requires a minimum 
sample size of 29 patients.  
The minimum sample size for both analyses is achieved in study II, 
where the sample size is 146 for the Bland-Altman plot and 123 for 
the correlation calculations. 
 
 
Study III considerations - Pain 
 
Study III examines pain as a risk factor for the development of non-
union. In the study current pain from the fracture site is reported on a 
visual analogue scale (VAS). The reporting of pain on a visual 
analogue scale has been widely studied and used since the 1970s, and 
is considered to have good reliability and construct validity70–75. Study 
III does not further explore a single absolute pain score at week four 
as a possible predictor. This is due to the fact that a range of different 
characteristic such as age, race, gender and socioeconomic status76–79 
influence pain perception. Some of this influence disappears when 
pain changes over time are examined80.  As pain reported on the 
visual analogue scale have ratio properties81–86 we believe that 
VASratio has the potential to exhibit good clinical reliability. The 
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minimal clinical important difference in patients with acute pain was 
in a large systematic review found to be between 8 – 40 mm on a 100 
mm scale87. The authors find that patients with higher pain require 
greater decrease to perceive relief, and conclude that relative changes 
in pain is a more stable indicator of clinically important difference. 
This further supports the use of the ratio properties of VAS in our 
study. 
Study III considerations - Prediction modelling 
 
Unfortunatly the small sample size in study does not allow for the 
development of a predictor model. Prediction models should be 
internal and external validated88–92 before widespread clinical use. In 
general interval validation is used as a tool to evaluate and correct the 
overfitting/optimism of the model, and external validation is a tool to 
assess the generalizability of the predictor model88–92. For internal 
validation with an event rate of 17.2 per cent a sample size of 219 
patients would be required93, and as a rule of thumb a mimium of 100 
events94 is required for external validation. Thus our dataset of 64 
subjects only allows for an examination of the possible association 
between pain and non-union risk. 
 
5.12 Study Statistics 
 
All statistical analysis was conducted using Stata (versions 13.1 - 
15.0, Stata Corp, College Station, Texas) and R95. Data was examined 
for normality with histograms and QQ-plots and Shapiro-Wilk test. 
Patient demographics were reported using descriptive statistics.  
Continuous variables were analyzed using Student’s t-test for 
normally distributed data and Mann–Whitney U test for non-Gaussian 
distributed data. Categorical variables were tested using chi-squared 
test or Fisher’s exact test if one value was five or less. In study II an 
inverted DASH (iDASH equal to 100 minus DASH) score was used. 
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 The level of significance was set at p < 0.05. A full presentation of 


















6. Main Results 
 
6.1 Study flow diagram 
 
167 patients were assessed for eligibility and 150 patients were 
enrolled and randomized 1:1 to either operative or non-operative 
treatment. At study completion 60 patients in the non-operative group 
and 64 patients in the operative group were available for analysis (Fig. 







Fig. 4.  Study 1 CONSORT flow chart. Unedited, pre-publication version 
reproduced with permission and copyright © of the British Editorial Society of Bone 







Table 2. Patient demographics and fracture morphology. Unedited, pre-publication 
version reproduced with permission and copyright © of the British Editorial Society 










DASH and Constant score were of normal distribution only at 6 
weeks follow-up. Due to ceiling effect data was heavily skewed at 
subsequent follow-up and Mann–Whitney U test was used for all 
analysis of DASH and Constant score. Both DASH (Fig. 5) and 
Constant score were significantly better in the operated group at six 
weeks and three months (p < 0.001 at six weeks and p = 0.02 at three 
months for both scores). At six months and 12 months follow-up there 




Fig 5. Bar chart showing median Disabilities of the Arm, Shoulder and Hand 
(DASH) scores during follow-up. Error bars indicate interquartile range. Unedited, 
pre-publication version reproduced with permission and copyright © of the British 




Eleven patients out of 63 patients (17%, 95% CI 9.1 to 29.1) in the 
non-operative treatment group developed a non-union. In the 
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operative treatment group, 2 patients out of 65 patients (3%, 95% CI 
0.0 to 7.1) developed non-union, which was significantly fewer than 
in the non-operative group (p = 0.009) (Table XXX). 11 of the non-
unions in the non-operative treatment group were symptomatic and 
nine patients underwent a secondary surgical procedure for non-union. 
In the operative treatment group, the first non-union case was treated 
with only two screws in each main fragment instead of three as per 
protocol. The second non-union occurred in a patient, who declined 
surgery after randomization to the operative treatment group. The 
patient was followed in the operative group according to the intention-
to-treat principle59. The number-needed-to-treat (NNT) operatively in 
order to avoid one nonunion was seven.  
 
 Treatment Union (n) Non-union (n) 
Non-operative 52 11 
Operative 63 2 
 




One patient in the operative treatment group was revised due to 
hardware failure, where perioperative cultures subsequently showed 
Cutibacterium. The major reason for secondary surgery in the 
operative treatment group was removal of symptomatic metalwork, 
which occurred in 16 patients (25%, 95% CI 16.0 to 36.8) after six 
months. One patient sustained a new fracture after plate removal, 
more medial than the index fracture. This fracture healed after non-
operative treatment. After one year, complaints of dysaesthesia around 
and below the fracture site were present in 13 patients (21%, 95% CI 
13.3 to 33.6) in the non-operative group and 44 patients (70%, 95% 
CI 55.6 to 77.8) in the operative group. 
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6.3 Study II 
 
In study II, 146 patients were included. 71 patients were from the non-
operative treatment group and 75 were from the operative treatment 
group. Overall, we found similar measument properties between 




The correlation between iDASH and CS decreased increasing follow-
up and was found to be high at six weeks, three months and six 




























Fig. 6.  
Scatterplots of inverted Disabilities of the Arm, Shoulder and Hand (iDASH) and 
Constant-Murley score (CS) at (A) six weeks follow-up and (B) one year follow-up. 
r, Spearmans Rank correlations coefficient. n, number of subjects. Reprinted from 




































At six weeks follow-up the Bland Altman plot (Fig. 7) showed a mean 




Bland-Altman plot of the means of inverted Disabilities of the Arm, Shoulder and 
Hand (iDASH) and Constant-Murley score (CS) versus the differences between 
iDASH and CS. Top dashed line indicates upper limits of agreement, while lower 
dashed line indicates lower limits of agreement. Middle dashed line indicates mean 
bias. Dotted lines show 95 per cent confidence intervals around agreements and 











6.4 Study III  
 
The cohort for study III consisted of 63 non-operatively treated 
patients available at six months follow-up and one patient in the 
operative treatment group who declined surgery after randomization.  
We saw a deviation in mean VAS score over time between the two 
groups (Fig 8.). 
This deviation in VAS score was confirmed by our linear mixed 
effects analysis. After visual inspection of our linear mixed effects 
model we defined VASratio as pain score from week four divided by 
pain score from week two. 
 
 
Fig 8. Mean patient reported pain on a visual analogue scale the first six weeks 








Pain score at week four (odds 1.84 per 1 point, 95% confidence 
intervals (CI) 1.08 to 3.4) and VASratio (odds 1.06 per 0.01 point 95% 
CI 1.02 – 1.11) were identified as independent predictors via logistic 
regression  
 
VASratio cohort analysis 
 
After treating VASratio as an exposure to a risk factor we used different 
VASratio cut-off points to analyse the cohort in various risk scenarios 




Cut-off 0.20  
 
 Union (n) 
Symptomatic 
non-union (n) 
Exposed 41 11 
Control 12 0 
AR = 21.2 %  (95% CI 11.1 – 34.7) 







Cut-off 0.60  
 
 Union (n) 
Symptomatic 
non-union (n) 
Exposed 13 10 
Control 40 1 
AR = 43.5 % (95% CI 23.2 –63.7) 








 Union (n) 
Symptomatic 
non-union (n) 
Exposed 2 3 
Control 51 8 
AR = 60 % (95% CI 14.7 – 95.0)  
RR = 4.4 (95% CI 1.7 - 11.6) 
 
Table 4. Analysis of cohort at various VASratio cut-off points.  Exposed group consist 
of patients above VASratio cut-off point. A = VASratio cut off at 0.20, B = VASratio cut 
off at 0.6, C = VASratio cut off at 1.00. AR and RR = Absolute Risk and Relative Risk 
of symptomatic non-union in exposed group. (CI = Confidence Interval). Adapted 
























ROC curve analysis showed that VASratio (AUC 0.84 95% CI 0.72 to 
0.96) has acceptable discrimination96(Fig. 9). 
 
 
Fig 9. Receiver operating characteristics curve using VASratio as a predictor for 
symptomatic non-union.  AUC = 0.84 (95% CI 0.72 to 0.96). Blue shade indicates 










In study I we found that operative treatment gives early 
improvements in functional outcome, but this difference 
between operative and non-operative treatment is not maintained 
and after six months there is no difference between the two 
groups. We cannot reject the null hypothesis for study I. Only 
one randomized trial16 has shown a 10 point relevant difference 
in functional outcome scores after one year follow-up. All other 
randomized trials have shown less than 10 points 
difference10,18,19 or no difference17,20,21 at end-analysis, which is 
similar to our findings. It is important to notice that some 
trials10,18,21 include untreated non-unions in end-analysis, and the 
exclusion of untreated non-unions from end-analysis improves 
functional outcomes for non-operative treatment18. In this study 
both treated and untreated non-unions were included according 
to the intention to treat principle, to reflect a true clinical setup. 
Furthermore we found that operative treatment of midshaft 
clavicular fractures reduces the risk of non-union from seventeen 
to three percent. This risk reduction benefit of operative 
treatment has been shown several times previously2,22. The NNT 
to avoid one non-union was 7, which is similar to the findings in 
Woltz’ metaanalysis of randomized controlled trials22. The main 
complication following operative treatment was symptomatic 
hardware, which resulted in reoperation for twenty-five percent 
of the patients. In studies that systematically reported the need 
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for plate removal10,18–21, the removal rates range from 3 percent 
to 17 percent. In a metaanalysis of recent randomized trials22 
ninety-five per cent of secondary surgical procedures in the 
operative treatment group was due to symptomatic hardware. 
Serious adverse events such as implant failure or infection 
account for sixteen and eleven per cent respectively. 
As previolusy decribed in study considerations it is possible that 
our high rate of plate removals in study I is study induced due to 
routinely presenting patients with the option of plate removal 




In study II we demonstrated good convergent validity between DASH 
and CS. The null hypothesis is rejected and the alternative hypothesis 
is accepted. The correlation between DASH and CS score was found 
to be moderate to high. Correlation decreased with increasing follow-
up, possibly due to the increasing ceiling effect and decreasing 
number of subjects. In a wide range of studies including a study on 
clavicular fractures40–43 good correlation between DASH and CS has 
been found, which is consistent with our findings, but simply 
demonstration correlation between two methods of measurement is 
not enough to establish convergent validity97. A Bland-Altman plot 
was constructed to further investigate the agreement between DASH 
and CS.  A small bias between DASH and CS of 2.21 points was 
found in the Bland-Altman plot. To our knowledge this is the first 
study to construct a Bland-Altman plot of DASH and CS in patients 
with clavicular fractures. Support for our finding of a small mean bias 
in the Bland-Altman plot could be indirectly drawn from Woltz’ 




The convergent validity between DASH and CS allows for the sole 
use of either score in future studies. Abandoning CS means 
abandoning a score that arbitrary combines subjective and 
objective measurement with no reasoning for the selection of 
items or weight of each item. This lack of underlying logic 
surrounding the CS is in stark contrast to the DASH 
questionnaire, which was developed with a systematic approach 
and a defined purpose15. Furthermore the objective part of CS 
creates a logistic and economic burden compared to DASH, where no 
trained personal or ambulatory visits are necessary in order to obtain 
the score. We suggest that only DASH is used in future studies of 





In study III we found that minimal pain reduction from week two to 
week four is associated with a high risk of symptomatic non-union. 
The null hypothesis is rejected and the alternative hypothesis is 
accepted. The absolute risk of non-union increased with increasing 
VASratio. VASratio was found to be an excellent discriminator and a 
cut-off of 0.58 was the optimal value in a model predicting the risk of 
symptomatic non-union. Compared to the predictive value of DASH 
score at 6 weeks following fracture56 with a AUC of 0.70 (95% CI 
0.53 to 0.89), the discrimination ability of VASratio (AUC 0.84 (95% 
CI 0.72 to 0.96) is superior. We did not find DASH score at 6 weeks 
to be associated with nonunion in our study. Our findings of an 
association between pain and non-union along with the previous 
findings of Nowak54, Clement53,56 and Nicholson57 suggests that proxy 
variables for healing exists as theorized in  Fig 2. This allows for the 









As described previously the definition of non-union varies across the 
literature. In study I the rate of non-union was 17 percent. The rate of 
non-union in randomized trials ranges from 4 percent16 to 24 
percent17. Due to the poor definition of non-union and variance in the 
defining time limit, the rate of non-union across the literature is 
difficult to compare. Comparing symptomatic non-union rates is even 





In study I we did not define malunion as a complication. The word 
malunion derives from the Latin word “malus” meaning “bad, evil, 
injurious, destructive, improper, wrong” or more figuratively “ill-
looking, deformed, defective”98. By its etymological origin a 
malunion is defined as a fracture healed in a deformity which 
compromises normal function. A possible consequence of this 
definition could be that the combination of a clavicular fracture healed 
in non-anatomic position and the presence of any complications 
would be classified as a malunion, as the definition of a deformity 
“which compromises normal function” is difficult. This could 
potentially lead to a malunion diagnosis for every complication 
following nonoperative treatment of displaced midshaft clavicular 
fractures. As described previously “a fracture healed with a 
deformity” and malunion are used synonymous in some of the 
literature33. Unfortunately the interchangeability of “a fracture healed 
with a deformity” and malunion, gives rise to the term “symptomatic 
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malunion” to describe a deformed healed fracture combined with 
symptoms attributed to the deformity. This term “symptomatic 
malunion” is an oxymoron based on the etymological origin of 
malunion, where the union already is “evil”. Since complications 
following non-operatively treated midshaft clavicular fractures can 
range from specific neurological and vascular complications34 to the 
more broad complications such as dysfunction and pain13,33, the term 
“symptomatic malunion” becomes nothing more than a poorly defined 
umbrella term. More relevant prefixes could be “radiological” or 
“clinical” when describing the malunion, but solid definitions of these 
terms does not exist. 
To avoid a poorly defined term we seeked to examine each 
complication individually and then classify the complication as 
neurological, vascular, infectious or other. Allthough the assocation 
was not shown in a large systematic review35, some studies reports 
association between shortening and malunion. It is possible that 
fracture shorting in these studies is a surrogate marker of tissue 
damage, as theoretically more initial traumatic force is required in 
fracutures with a high amount of shortening and displacement 
compared to undisplaced fractures. The pain and discomfort (a “poor” 
outcome) attributed to malunion could be secondary to the initial 
damage of the surrounding tissue when the fracture occurs. It is 
however uncertain if operative treatment reduces the rate of patients 
with a “poor” outcome, if the outcome is dependant on the level of 
tissue damage. To truely investigate the clinical relevance of malunion 









Drop out and sample size calculation 
 
A risk of type 2 error arises in study I, as only 60 patients were 
available for end point analysis in the non-operative treatment arm. 
The sample size calculation assumed a standard deviation in DASH of 
20 points. Randomized controlled trials conducted after the initial 
sample size calculation all have a lower standard deviation, where the 
highest deviation is 13.5 points17. 
Using this standard deviation a new sample size for each group is 
calculated as: 
na =((Za + Z1-b)2 x 2 × σ2)/d2 
na= ((1.96 + 0.84) 2 2 x 13.52))/102  
na=(7.84 x 2 x 400)/100 = 28.5 
As a sample size calculation based on a more realistic standard 
deviation only requires 29 patients in each group, we estimate the 
risk of type 2 error due to lack of power to be low.  
 
Limits of agreement 
 
In study II the Bland-Altman plot shows wide limits of agreement 
ranging from -20.3 to 24.7 points. This is without consequence as the 
aim of the study was to investigate the difference between DASH and 







Predictors of non-union. 
 
We found no association between non-union and age, gender, fracture 
comminution or shortening. This could possibly be due to our low 
sample size and lack of power to detect an association. Alternatively a 
strong association between non-union and age, gender, fracture 
comminution or shortening does not exist. Evidence for these 
associations has been previously shown by Jørgensen31 to be limited. 
Interestingly Clement56 also examined pain as possible predictor, 
where patients were asked to grade their pain at 6 weeks as “none, 
mild, moderate or severe”. Although 16 of 79 patients in the union 
group indicated no pain after six weeks, compared to only one of 17 in 
the non-union group, no association between pain and non-union was 
found. This lack of association could be due to the measurement of 
pain on a categorical scale at a single time point. Our study did not 
have the power to develop a prediction model. However the 
association between non-union and pain could have been further 
investigated given an external dataset. Unfortunately e-mail contact to 
the authors of the recent published randomized trials did not provide 
such a dataset. The predictive value of VASratio remains to be proven 
before widespread clinical use. 
 
Loss to follow-up and study III 
 
The outcome in study III is non-union. We do not know the non-union 
rates for patients lost to follow-up. It is entirely possible that patients 
with early dropout abandoned the study due to pain issues in order to 
seek treatment elsewhere. As we have shown that early minimal pain 
reduction is associated with a high risk of non-union it is possible that 
some potential non-unions are missing from the study along with their 
pain profile. This is however not a severe limitation, as these 
hypothetical patients would only further strengthen the association 










Operative treatment with precontoured plates and locking screws of 
displaced midshaft clavicular fractures gives higher union rates 
compared with non-operative treatment. After six months there is no 
difference in functional outcome score between the two groups. 
Osteosynthesis almost eliminates the risk of non-union, but routinely 
operating all fractures is not recommended due to the risk of 
complications following operative treatment, including the high risk 
of exposing many patients to unneccesary surgery. It may be possible 
to reduce the overall group risk of non-union by offering operative 
treatment to patients at high risk of developing a non-union. Minimal 
pain reduction in the early weeks after fracture is associated with a 
high risk of developing a symptomatic non-union, but this association 
needs to be externally validated, before a treatment algorithm is put to 
clinical use. In future studies DASH could be used as the sole 
functional outcome, as there is good convergent validity between 








9. Treat-all, treat-none or treat-some? 
Perspectives and suggestions for future research.  
 
Research questions asked in randomized trials often yields a strict 
binary response (treatment: yes/no) and the results from these trial are 
often (mis)used to adapt a “treat-all” or “treat-none” approach. 
The current evidence on the treatment of midshaft clavicular fractures 
points towards a “treat-none” approach, as the only benefit of 
treatment is the reduced risk of non-union, and the NNT to avoid one 
non-union is deemed to high in contrast to the risk of complications 
associated with surgery. 
A different approach could be “treat-some”, where only patients at 
high risk of developing a non-union would be offered surgery. Study 
III suggests that minimal pain reduction in the early weeks following 
fracture could be a key component in the development of new 
treatment algorithm.  The end goal of individualized treatment is the 
reduction of the risk of non-union along with a reduced risk of 
surgical complications for the whole group.  
The treat-some approach could also contain patients, who opt for 
primary operative treatment. The group includes high demand patient 
such as athletes (overhead sport or cycling), or patients not willing to 
accept even a low risk of non-union. 
In study III we only show an association between pain and non-union 
risk, and conclude that these findings should be externally validated 
before clinical implementation.  
This validation before clinical implementation poses a challenge, as 
true external validation of a predictive model requires a dataset of 
minimum 100 events94. As discussed in the study II paper a dataset of 
this size would take 18 years years to collect using the original study 
setup.  
A more pragmatic approach would be a new study where the “treat-
some” algorithm (with an arbitrary VASratio cut-off point) is compared 
with the “treat-none” approach. In this new study functional results 
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could be obtained with DASH score alone, as we in study II have 
shown no need for the simultaneous use of DASH and CS in future 
studies. 
Should the “treat-some” algorithm prove to be superior, a successful 
nationwide clinical implementation could be proved in register studies 
following the years after implementation, where one would a expect 
to see a reduction in the nationwide rate of non-union along with a 
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